BG106351A - Заместени феноксиоцетни киселини - Google Patents
Заместени феноксиоцетни киселини Download PDFInfo
- Publication number
- BG106351A BG106351A BG06351A BG10635102A BG106351A BG 106351 A BG106351 A BG 106351A BG 06351 A BG06351 A BG 06351A BG 10635102 A BG10635102 A BG 10635102A BG 106351 A BG106351 A BG 106351A
- Authority
- BG
- Bulgaria
- Prior art keywords
- fluoro
- phenoxy
- acetic acid
- benzylcarbamoyl
- bromo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/48—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14106899P | 1999-06-25 | 1999-06-25 | |
PCT/US2000/017377 WO2001000566A2 (en) | 1999-06-25 | 2000-06-23 | Substituted phenoxyacetic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
BG106351A true BG106351A (bg) | 2002-09-30 |
Family
ID=22494031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG06351A BG106351A (bg) | 1999-06-25 | 2002-01-25 | Заместени феноксиоцетни киселини |
Country Status (24)
Country | Link |
---|---|
US (4) | US6420426B1 (no) |
EP (1) | EP1198451A2 (no) |
JP (1) | JP2003503381A (no) |
KR (1) | KR20020013936A (no) |
CN (1) | CN1364153A (no) |
AP (1) | AP2001002377A0 (no) |
AU (1) | AU5886900A (no) |
BG (1) | BG106351A (no) |
BR (1) | BR0011928A (no) |
CA (1) | CA2385798A1 (no) |
CZ (1) | CZ20014637A3 (no) |
EE (1) | EE200100708A (no) |
HU (1) | HUP0202384A3 (no) |
IL (1) | IL147197A0 (no) |
MX (1) | MXPA02003123A (no) |
NO (1) | NO20016272L (no) |
NZ (1) | NZ516290A (no) |
OA (1) | OA11972A (no) |
PL (1) | PL355857A1 (no) |
SK (1) | SK19152001A3 (no) |
TN (1) | TNSN00139A1 (no) |
TR (1) | TR200200619T2 (no) |
WO (1) | WO2001000566A2 (no) |
ZA (1) | ZA200200300B (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1364153A (zh) * | 1999-06-25 | 2002-08-14 | 制药发现学会股份有限公司 | 取代的苯氧基乙酸 |
US6680387B2 (en) | 2000-04-24 | 2004-01-20 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
US6958355B2 (en) | 2000-04-24 | 2005-10-25 | Aryx Therapeutics, Inc. | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
US6768008B2 (en) * | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
KR100356374B1 (ko) * | 2000-09-14 | 2002-10-19 | 사회복지법인삼성생명공익재단(삼성서울병원) | 안지오텐신 전환효소 억제제의 부작용으로 발생하는마른기침을 저해하기 위한 철분을 포함하는 기침 저해조성물 |
AU2001294673A1 (en) | 2000-09-21 | 2002-04-02 | Aryx Therapeutics | Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis |
JP2005502600A (ja) * | 2001-06-07 | 2005-01-27 | イーライ・リリー・アンド・カンパニー | ペルオキシソーム増殖因子活性化受容体(ppar)のモジュレーター |
CN1751037A (zh) | 2003-02-14 | 2006-03-22 | 伊莱利利公司 | 作为ppar调节剂的磺酰胺衍生物 |
KR20060006953A (ko) * | 2003-04-30 | 2006-01-20 | 디 인스티튜트스 포 파마슈티컬 디스커버리, 엘엘씨 | 치환된 카르복실산 |
PL1750862T3 (pl) | 2004-06-04 | 2011-06-30 | Teva Pharma | Kompozycja farmaceutyczna zawierająca irbesartan |
EP1805136A1 (en) * | 2004-10-28 | 2007-07-11 | The Institutes for Pharmaceutical Discovery, LLC | Substituted phenylalkanoic acids |
GB0427603D0 (en) * | 2004-12-16 | 2005-01-19 | Novartis Ag | Organic compounds |
US10640457B2 (en) | 2009-12-10 | 2020-05-05 | The Trustees Of Columbia University In The City Of New York | Histone acetyltransferase activators and uses thereof |
CA2822621C (en) * | 2010-12-22 | 2020-12-15 | The Trustees Of Columbia University In The City Of New York | Histone acetyltransferase modulators and uses thereof |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
CN109289696B (zh) * | 2018-10-29 | 2022-03-22 | 天津先光化工有限公司 | 一种咪唑啉两性表面活性剂的制备方法 |
CN114790139B (zh) * | 2021-01-26 | 2024-06-18 | 江苏中旗科技股份有限公司 | 一种以2-氯-4-氨基溴苯为原料合成2-氯-4-氟苯甲酸的方法 |
CN114790133B (zh) * | 2021-01-26 | 2024-06-18 | 江苏中旗科技股份有限公司 | 一种以2-氯-4-氨基苯腈为原料合成2-氯-4-氟苯甲酸的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986005779A1 (en) | 1985-04-03 | 1986-10-09 | Yamanouchi Pharmaceutical Co., Ltd. | Phenylene derivatives |
JPH04297466A (ja) * | 1990-06-22 | 1992-10-21 | Nippon Shinyaku Co Ltd | テトラゾール誘導体及び医薬 |
WO1994008945A1 (de) * | 1992-10-16 | 1994-04-28 | Byk Nederland Bv | Substituierte ethanolaminester |
GB9511694D0 (en) | 1995-06-09 | 1995-08-02 | Fujisawa Pharmaceutical Co | Benzamide derivatives |
CN1364153A (zh) * | 1999-06-25 | 2002-08-14 | 制药发现学会股份有限公司 | 取代的苯氧基乙酸 |
-
2000
- 2000-06-23 CN CN00809446A patent/CN1364153A/zh active Pending
- 2000-06-23 WO PCT/US2000/017377 patent/WO2001000566A2/en not_active Application Discontinuation
- 2000-06-23 CZ CZ20014637A patent/CZ20014637A3/cs unknown
- 2000-06-23 BR BR0011928-8A patent/BR0011928A/pt not_active IP Right Cessation
- 2000-06-23 NZ NZ516290A patent/NZ516290A/xx unknown
- 2000-06-23 OA OA1200100338A patent/OA11972A/en unknown
- 2000-06-23 CA CA002385798A patent/CA2385798A1/en not_active Abandoned
- 2000-06-23 SK SK1915-2001A patent/SK19152001A3/sk unknown
- 2000-06-23 EE EEP200100708A patent/EE200100708A/xx unknown
- 2000-06-23 AU AU58869/00A patent/AU5886900A/en not_active Abandoned
- 2000-06-23 TN TNTNSN00139A patent/TNSN00139A1/fr unknown
- 2000-06-23 IL IL14719700A patent/IL147197A0/xx unknown
- 2000-06-23 JP JP2001506979A patent/JP2003503381A/ja active Pending
- 2000-06-23 HU HU0202384A patent/HUP0202384A3/hu unknown
- 2000-06-23 KR KR1020017016636A patent/KR20020013936A/ko not_active Application Discontinuation
- 2000-06-23 AP APAP/P/2001/002377A patent/AP2001002377A0/en unknown
- 2000-06-23 MX MXPA02003123A patent/MXPA02003123A/es unknown
- 2000-06-23 US US09/603,817 patent/US6420426B1/en not_active Expired - Fee Related
- 2000-06-23 PL PL00355857A patent/PL355857A1/xx not_active Application Discontinuation
- 2000-06-23 TR TR2002/00619T patent/TR200200619T2/xx unknown
- 2000-06-23 EP EP00944834A patent/EP1198451A2/en not_active Withdrawn
-
2001
- 2001-12-20 NO NO20016272A patent/NO20016272L/no not_active Application Discontinuation
-
2002
- 2002-01-14 ZA ZA200200300A patent/ZA200200300B/xx unknown
- 2002-01-25 BG BG06351A patent/BG106351A/bg unknown
- 2002-07-16 US US10/195,964 patent/US20030036558A1/en not_active Abandoned
-
2003
- 2003-09-12 US US10/662,135 patent/US7189749B2/en not_active Expired - Fee Related
-
2007
- 2007-03-13 US US11/685,336 patent/US20070161631A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2003503381A (ja) | 2003-01-28 |
US20070161631A1 (en) | 2007-07-12 |
HUP0202384A3 (en) | 2003-03-28 |
TR200200619T2 (tr) | 2003-01-21 |
WO2001000566A3 (en) | 2002-02-07 |
IL147197A0 (en) | 2002-08-14 |
OA11972A (en) | 2006-04-18 |
SK19152001A3 (sk) | 2002-06-04 |
BR0011928A (pt) | 2002-04-09 |
AU5886900A (en) | 2001-01-31 |
EE200100708A (et) | 2003-02-17 |
EP1198451A2 (en) | 2002-04-24 |
HUP0202384A2 (hu) | 2002-11-28 |
US20050239849A1 (en) | 2005-10-27 |
NO20016272D0 (no) | 2001-12-20 |
TNSN00139A1 (fr) | 2005-11-10 |
PL355857A1 (en) | 2004-05-31 |
AP2001002377A0 (en) | 2001-12-31 |
NO20016272L (no) | 2002-01-17 |
KR20020013936A (ko) | 2002-02-21 |
US7189749B2 (en) | 2007-03-13 |
US6420426B1 (en) | 2002-07-16 |
NZ516290A (en) | 2004-03-26 |
WO2001000566A2 (en) | 2001-01-04 |
ZA200200300B (en) | 2003-08-27 |
US20030036558A1 (en) | 2003-02-20 |
CA2385798A1 (en) | 2001-01-04 |
MXPA02003123A (es) | 2003-08-20 |
CN1364153A (zh) | 2002-08-14 |
CZ20014637A3 (cs) | 2002-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070161631A1 (en) | Substituted Phenoxyacetic Acids | |
KR101018318B1 (ko) | Gk 활성제로서의 아미드 유도체 | |
JP4759517B2 (ja) | 肥満症の処置のためのアリールアルキル酸誘導体の製造および使用 | |
CA2646430A1 (en) | Bicyclic carboxylic acid derivatives useful for treating metabolic disorders | |
CA2525628C (en) | New benzimidazole derivatives | |
JP2009501721A (ja) | レチノイン酸受容体における活性を伴う化合物 | |
SK7352001A3 (en) | Substituted indolealkanoic acids compounds and use thereof for reducing serum triglyceride levels | |
JP2002544254A (ja) | グルカゴンアンタゴニスト/逆アゴニスト | |
JP2006525365A (ja) | フェニル置換カルボン酸 | |
HU211138A9 (en) | Therapeutic amides | |
EA009201B1 (ru) | Фенил - или пиридиламидные соединения в качестве антагонистов простагландина e2 | |
BG65446B1 (bg) | Заместени индолалканови киселини | |
WO2003004458A1 (en) | New compounds | |
EP1996567A2 (en) | Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome | |
US8476255B2 (en) | Histone deacetylase inhibitors | |
KR101391746B1 (ko) | 인다논 유도체, 이의 약학적으로 허용되는 염 또는 이의 광학 이성질체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물 | |
JP2012532914A (ja) | テトラゾール誘導体 | |
JP2006524687A (ja) | バニロイド受容体で阻害活性を示す新規複素環アミド | |
WO2008087514A2 (en) | Hdac inhibitors | |
WO2013022951A1 (en) | Composition for treating diabetes and metabolic diseases and a preparation method thereof | |
EP0398179A1 (en) | Rhodanine derivatives and pharmaceutical compositions | |
EA003327B1 (ru) | Антивирусные соединения | |
WO2004046123A1 (en) | Benzoxazole, benzthiazole and benzimidazole derivatives useful as heparanase inhibitors | |
CN114761025B (zh) | PDIA4抑制剂及其用于抑制β细胞病变及治疗糖尿病的用途 | |
KR20050040338A (ko) | 알도오스 환원 효소 저해 활성을 갖는 화합물 |